Class IIa HDAC-4 stained 44% of benign and 36% of malignant tumors, mostly with a nuclear pattern, while 4 cases (different from the ones mentioned for HDAC-2) showed a cytoplasmic pattern of staining (3 PAs and 1 SCC). This evidence concerns the gene HDAC2 and cancer.